• Enitan D Carrol, Antony Payton, Deborah Payne, Fabio Miyajima, Mas Chaponda, Limangeni A Mankhambo, Daniel L Banda, Elizabeth M Molyneux, Helen Cox, Greg Jacobson, Daniel F Carr, Malcolm E Molyneux, James P Stewart, John P Quinn, C Anthony Hart, and William E Ollier.
• Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. edcarrol@liverpool.ac.uk
• J. Immunol. 2011 Feb 15;186(4):2329-35.

AbstractIL-1R antagonist (IL-1Ra) is required for adequate host defense in invasive pneumococcal disease (IPD). The minor allele of an IL1RN gene (C/T) promoter polymorphism (rs4251961) has been shown to be associated with decreased IL-1Ra production in healthy adults. We genotyped 299 children with IPD, and examined 19 IL1RN haplotype-tagging single-nucleotide polymorphisms. Human embryonic kidney HEK293(T) cells were transfected with the promoter reporter plasmid pGL3p containing either allelic variant C (pGL3pCC) or T (pGL3pTT) with or without cotransfection with an expression construct overexpressing the globin transcription factor GATA-1. Plasma IL-1Ra concentrations were significantly higher in nonsurvivors compared with survivors (p < 0.0005), and the C allele of rs4251961 was associated with a significant increase in plasma IL-1Ra concentrations (p = 0.01) during the acute illness of IPD. These findings were validated in a cohort of 276 treatment-naive HIV-infected adults, with borderline significance (p = 0.058). Functional analyses demonstrated that the activity of the promoter constructs containing the T allele increased ~6-fold as compared with basal activity, and that containing the C allele by ~9-fold (p < 0.001) in the presence of GATA-1. Our findings suggest that the IL-1Ra single-nucleotide polymorphism rs4251961 plays a key role in the pathophysiology of IPD and in other human infections.

35 keywords...

hide…